XML 86 R31.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):
December 31, 2025
Level 1Level 2Level 3Total
Money market funds (1)
$6,245 $— $— $6,245 
Total assets$6,245 $— $— $6,245 

Warrant liabilities$— $2,614 $$2,615 
Total liabilities$— $2,614 $$2,615 
December 31, 2024
Level 1Level 2Level 3Total
Money market funds (1)
$12,100 $— $— $12,100 
Total assets$12,100 $— $— $12,100 
Warrant liabilities$— $2,827 $$2,828 
Total liabilities$— $2,827 $$2,828 
___________________
(1) Included in cash, cash equivalents, and restricted cash on the consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following table presents a summary of changes in Level 3 in the fair value of the Company’s common stock warrant liabilities (in thousands):
December 31, 2025December 31, 2024
Balance, beginning of the period$$11 
Change in fair value— (10)
Balance, end of the period$$
Schedule of Fair Value Measurement Inputs and Valuation Techniques
The fair value of the Angion Warrant liabilities was estimated using the following assumptions:
December 31, 2025December 31, 2024
Weighted average strike price$76.00 $76.00 
Contractual term (years)2.73.7
Volatility (annual)67.6 %74.9 %
Risk-free rate3.8 %4.4 %
Dividend yield (per share)0.0 %0.0 %